Page last updated: 2024-08-17

sulfamic acid and Breast Cancer

sulfamic acid has been researched along with Breast Cancer in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.56)18.2507
2000's10 (55.56)29.6817
2010's5 (27.78)24.3611
2020's2 (11.11)2.80

Authors

AuthorsStudies
Dohle, W; Hargrave, SD; Joubert, AM; Marais, S; Mercier, AE; Potter, BVL1
Anbar, HS; El-Awady, R; El-Gamal, MI; El-Gamal, R; Foster, PA; Potter, BVL; Zaraei, SO1
Endo, Y; Kaise, A; Ohta, K; Shirata, C1
Potter, BV; Thomas, MP1
Bache, M; Emmerich, D; Güttler, A; Münch, C; Paschke, R; Theuerkorn, K; Vordermark, D; Wichmann, H1
Jaggi, AS; Shah, R; Singh, D; Singh, J; Singh, N1
Gao, M; Hutchins, GD; Mickens, J; Miller, KD; Sledge, GW; Wang, M; Zheng, QH1
Carta, F; Cecchi, A; Harrison, D; Kunkler, I; Langdon, SP; Mullen, P; Scozzafava, A; Supuran, CT; Ward, C; Winum, JY1
Golob, T; Liebl, R; von Angerer, E1
Leese, MP; Newman, SP; Potter, BV; Purohit, A; Reed, MJ; Suzuki, RN1
Billich, A; Nussbaumer, P; Winiski, AP1
Fujii, T; Iwashita, S; Koizumi, N; Nakagawa, T; Okada, M; Takegawa, S1
Liebl, R; von Angerer, E; Walter, G1
Leese, MP; Potter, BV; Purohit, A; Raobaikady, B; Reed, MJ1
De Simone, G; Di Fiore, A; Leblond, B; Leese, MP; Newman, SP; Potter, BV; Purohit, A; Reed, MJ; Smith, A; Supuran, CT1
Howarth, NM; Potter, BV; Purohit, A; Reed, MJ1
Barrow, D; Hejaz, HA; Nicholson, RI; Potter, BV; Purohit, A; Reed, MJ; Woo, LW1
Bradshaw, TD; Chua, MS; Shi, DF; Stevens, MF; Westwell, AD1

Reviews

1 review(s) available for sulfamic acid and Breast Cancer

ArticleYear
Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review.
    European journal of medicinal chemistry, 2016, May-23, Volume: 114

    Topics: Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Neoplasm Recurrence, Local; Sulfatases; Sulfonic Acids

2016

Other Studies

17 other study(ies) available for sulfamic acid and Breast Cancer

ArticleYear
Cell Fate following Irradiation of MDA-MB-231 and MCF-7 Breast Cancer Cells Pre-Exposed to the Tetrahydroisoquinoline Sulfamate Microtubule Disruptor STX3451.
    Molecules (Basel, Switzerland), 2022, Jun-14, Volume: 27, Issue:12

    Topics: 2-Methoxyestradiol; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Humans; MCF-7 Cells; Microtubules; Sulfonic Acids; Tetrahydroisoquinolines

2022
A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation.
    Bioorganic & medicinal chemistry, 2020, 04-15, Volume: 28, Issue:8

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell-Free System; Female; Humans; Inhibitory Concentration 50; Molecular Structure; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonic Acids

2020
Design and synthesis of p-carborane-containing sulfamates as multitarget anti-breast cancer agents.
    Bioorganic & medicinal chemistry, 2017, 12-15, Volume: 25, Issue:24

    Topics: Antineoplastic Agents; Apoptosis; Boranes; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Female; Humans; Microtubules; Molecular Structure; Structure-Activity Relationship; Sulfonic Acids

2017
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
    Journal of medicinal chemistry, 2015, Oct-08, Volume: 58, Issue:19

    Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Discovery; Endometriosis; Estrone; Female; Humans; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Steryl-Sulfatase; Sulfonic Acids; Tubulin Modulators

2015
Betulinyl Sulfamates as Anticancer Agents and Radiosensitizers in Human Breast Cancer Cells.
    International journal of molecular sciences, 2015, Nov-03, Volume: 16, Issue:11

    Topics: Antineoplastic Agents; Apoptosis; Biomarkers; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Female; Humans; Inhibitory Concentration 50; Radiation-Sensitizing Agents; Sulfonic Acids; Tumor Stem Cell Assay

2015
Design and synthesis of carbon-11-labeled dual aromatase-steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer.
    Steroids, 2009, Volume: 74, Issue:12

    Topics: Aromatase; Aromatase Inhibitors; Breast Neoplasms; Carbon Radioisotopes; Drug Design; Gene Expression Regulation, Neoplastic; Isotope Labeling; Positron-Emission Tomography; Radiochemistry; Steryl-Sulfatase; Sulfonic Acids

2009
Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines.
    Bioorganic & medicinal chemistry letters, 2012, Jul-15, Volume: 22, Issue:14

    Topics: Breast Neoplasms; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Line, Tumor; Cell Proliferation; Humans; Molecular Structure; Structure-Activity Relationship; Sulfonic Acids

2012
Sulfamoyloxy-substituted 2-phenylindoles: antiestrogen-based inhibitors of the steroid sulfatase in human breast cancer cells.
    Bioorganic & medicinal chemistry, 2002, Volume: 10, Issue:12

    Topics: Arylsulfatases; Breast Neoplasms; Estrogen Receptor Modulators; Female; Humans; Indoles; Inhibitory Concentration 50; Neoplasm Proteins; Radioligand Assay; Steryl-Sulfatase; Structure-Activity Relationship; Sulfatases; Sulfonic Acids; Tumor Cells, Cultured

2002
Growth inhibition of multi-drug-resistant breast cancer cells by 2-methoxyoestradiol-bis-sulphamate and 2-ethyloestradiol-bis-sulphamate.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 84, Issue:2-3

    Topics: 2-Methoxyestradiol; Biocompatible Materials; Breast Neoplasms; Cell Cycle; Cell Division; Collagen; Drug Combinations; Estradiol; Estriol; G2 Phase; Humans; Laminin; Mitosis; Models, Chemical; Plastics; Proteoglycans; Sulfonic Acids; Tumor Cells, Cultured

2003
Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
    Journal of medicinal chemistry, 2003, Nov-06, Volume: 46, Issue:23

    Topics: Benzopyrans; Binding, Competitive; Breast Neoplasms; Cell Division; Cell Line, Tumor; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Fluorescence Polarization; Humans; Ligands; Receptors, Estrogen; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonic Acids

2003
Development of novel steroid sulfatase inhibitors. I. Synthesis and biological evaluation of biphenyl-4-O-sulfamates.
    The Journal of steroid biochemistry and molecular biology, 2003, Volume: 87, Issue:2-3

    Topics: Animals; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrone; Female; Humans; Liver; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonic Acids; Uterus

2003
2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
    The Journal of steroid biochemistry and molecular biology, 2004, Volume: 88, Issue:4-5

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Estrone; Female; Gene Expression Regulation, Neoplastic; Humans; Hydrolysis; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Receptors, Estrogen; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonic Acids; Transcriptional Activation

2004
Inhibition of MDA-MB-231 cell cycle progression and cell proliferation by C-2-substituted oestradiol mono- and bis-3-O-sulphamates.
    International journal of cancer, 2005, Oct-20, Volume: 117, Issue:1

    Topics: 2-Methoxyestradiol; Breast Neoplasms; Cell Division; Cell Proliferation; Collagen; Drug Combinations; Estradiol; Estrogen Receptor alpha; Female; G2 Phase; Humans; Laminin; Phosphorylation; Proteoglycans; Proto-Oncogene Proteins c-bcl-2; Sulfonic Acids; Tumor Cells, Cultured; Tumor Stem Cell Assay

2005
2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity.
    Journal of medicinal chemistry, 2006, Dec-28, Volume: 49, Issue:26

    Topics: Animals; Antineoplastic Agents; Binding Sites; Breast Neoplasms; Carbonic Anhydrase II; Carcinoma, Lewis Lung; Cell Proliferation; Crystallography, X-Ray; Estradiol; Female; Humans; Mice; Mice, Nude; Models, Molecular; Neovascularization, Pathologic; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonic Acids; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zinc

2006
Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential.
    Journal of medicinal chemistry, 1994, Jan-21, Volume: 37, Issue:2

    Topics: Breast Neoplasms; Cell Division; Drug Screening Assays, Antitumor; Estrone; Humans; Sulfatases; Sulfonic Acids; Tumor Cells, Cultured

1994
Non-steroidal and steroidal sulfamates: new drugs for cancer therapy.
    Molecular and cellular endocrinology, 2001, Jan-22, Volume: 171, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Coumarins; Enzyme Inhibitors; Estrogens; Estrone; Female; Humans; Kinetics; Oxepins; Rats; Rats, Wistar; Sulfatases; Sulfonamides; Sulfonic Acids; Tumor Cells, Cultured

2001
Antitumour benzothiazoles. Part 15: The synthesis and physico-chemical properties of 2-(4-aminophenyl)benzothiazole sulfamate salt derivatives.
    Bioorganic & medicinal chemistry letters, 2001, Apr-23, Volume: 11, Issue:8

    Topics: Amines; Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Drug Stability; Enzyme Activators; Female; Guanylate Cyclase; Humans; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Platelet Aggregation Inhibitors; Prodrugs; Solubility; Sulfonic Acids; Thiazoles; Tumor Cells, Cultured

2001